Furthermore, we showed that the ILC2-activating mediators IL-33, IL-18, and prostaglandin D2 (PGD2) are increased in the serum of patients with PCa, suggesting that they play a key role in sustaining ILC2 proliferation and activity. This evidence concerns the gene IL33 and posterior cortical atrophy.